InspireMD Reports Second Quarter 2023 Financial Results and Provides Business Update

Go back to InspireMD Reports Second Quarter 2023 Financial Results and Provides Business Update

InspireMD (NSPR) Tops Q2 EPS by 19c

August 8, 2023 7:10 AM EDT

InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.24), $0.19 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.8 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

... More